Vioxx and Reading disorder - a phase IV clinical study of FDA data

Summary:

Reading disorder is reported as a side effect among people who take Vioxx (rofecoxib), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Serzone, and have Joint pain.

The phase IV clinical study analyzes which people have Reading disorder when taking Vioxx. It is created by eHealthMe based on reports of 110,097 people who have side effects when taking Vioxx from the FDA, and is updated regularly.

What is Vioxx?

Vioxx has active ingredients of rofecoxib. It is often used in arthritis. eHealthMe is studying from 110,130 Vioxx users. Check the latest studies of Vioxx.

What is Reading disorder?

Reading disorder (problem in areas of the brain that help interpret language) is found to be associated with 297 drugs and 474 conditions by eHealthMe. Check the latest studies of Reading disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

110,097 people reported to have side effects when taking Vioxx.
Among them, 18 people (0.02%) have Reading disorder.

Among these 18 people:

How long have people been on Vioxx when they have Reading disorder? *

What is the gender of people who have Reading disorder when taking Vioxx? *

female: 77.78 %
male: 22.22 %

What is the age of people who have Reading disorder when taking Vioxx? *

What are other drugs people take besides Vioxx? *

What are other side effects people have besides Reading disorder? *

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 10 people, 55.56%
Headache (pain in head): 10 people, 55.56%
Dyspnea (difficult or laboured breathing): 9 people, 50.00%
High Blood Pressure: 7 people, 38.89%
Depression: 7 people, 38.89%
Disturbance In Attention: 7 people, 38.89%
Dizziness: 7 people, 38.89%
Chest Pain: 7 people, 38.89%
Sleep Apnea Syndrome: 7 people, 38.89%
Lacunar Infarction (a type of stroke): 6 people, 33.33%

What are the existing conditions these people have? *

Joint Pain: 4 people, 22.22%
High Blood Pressure: 3 people, 16.67%
Spinal Osteoarthritis (joint cartilage loss in spine): 2 people, 11.11%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 11.11%
High Blood Cholesterol: 2 people, 11.11%
Glaucoma (increased fluid pressure in the eye with vision loss): 2 people, 11.11%
Diabetes: 2 people, 11.11%
Depression: 2 people, 11.11%
Thyroid Diseases: 1 person, 5.56%
Limb Injury: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Vioxx and have Reading disorder?

- Check whether Reading disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vioxx:

Vioxx (110,130 reports)

Browse all side effects of Vioxx:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Reading disorder:

Reading disorder (297 drugs)

Browse all the conditions that are associated with Reading disorder:

Reading disorder (474 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rofecoxib (the active ingredients of Vioxx) and Vioxx (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.